Eli Lilly & Company (NYSE:LLY) ranks among the stocks to benefit from an onshoring boom. On July 22, BMO Capital reaffirmed ...

Eli Lilly ( LLY 0.64%) has been one of the best-performing pharmaceutical leaders in the past five years. Thanks to strong ...

Talking about Morgan Stanley’s bullish call on Eli Lilly and Company (NYSE:LLY), Kevin Simpson, Capital Wealth Planning founder and CIO, said that he agrees with the call and thinks the company’s ...

We recently published a list of the 10 Best Long-Term Dividend Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY ...

In recent times, though, Lilly has become less expensive, as the stock slipped 12% from a high reached in March. Is Lilly a buy on the dip? Let's find out. Image source: Getty Images.

ENDOWMENT INC LILLY has made 0 purchases and 51 sales selling 534,452 shares for an estimated $474,544,560. DANIEL SKOVRONSKY (EVP, CSO & Pres. LRL & LLY Imm) has made 0 purchases and 3 sales ...

Eli Lilly Revenue Up on Demand for Mounjaro, Other Weight-Loss Meds The drug maker’s net income came in at $2.76 billion, or $3.06 a share, up from $2.24 billion, or $2.48 a share, in the prior ...

Eli Lilly isn't done in developing new weight loss treatments. In fact, the best may still be to come, as it's working on a pill, which could be a game changer for the industry.